CONSULTING AGREEMENTConsulting Agreement • March 28th, 2023 • NexImmune, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledMarch 28th, 2023 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), effective as of April 1, 2023 (the “Effective Date”), is entered by and between NexImmune, Inc., a Delaware corporation with its principal place of business at 9119 Gaither Road, Gaithersburg, Maryland 20877 (“NexImmune” or the “Company”), and Jerome Zeldis, M.D., Ph.D, an individual (“Consultant”).